Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEEEH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,347
Award facts
- Contract value 100% obligated
- $14,346.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,346.99 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on November 17, 2025, with an ultimate completion date of November 20, 2025, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations, drawing from its comprehensive product portfolio that includes branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and oncology treatments.
This delivery order is issued under DMS Pharmaceutical Group's recently awarded Indefinite Delivery Contract (IDC) designated SPE2DR under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling and completion date of December 31, 2036. The PPV-G GEN V is part of a broader $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to serve as critical pharmaceutical suppliers for Department of Defense healthcare operations globally. The IDC structure authorizes DLA to issue firm fixed-price delivery orders for recurring medical supply needs across military healthcare facilities worldwide, with DMS Pharmaceutical Group's established performance on numerous prior awards demonstrating its capability to fulfill the diverse and specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FEEEH?
SPE2DU26FEEEH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DU26FEEEH worth?
The government has obligated $14,347 on SPE2DU26FEEEH.
Is contract SPE2DU26FEEEH an order under another contract?
Yes. SPE2DU26FEEEH is a delivery order under SPE2DU25D9439, an indefinite delivery contract.
Was contract SPE2DU26FEEEH competed?
The extent of competition for SPE2DU26FEEEH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award